𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of seminal vesicle-sparing radical prostatectomy on serum prostate-specific antigen level

✍ Scribed by H. John; D. Hauri; C. Maake

Book ID
109050837
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
129 KB
Volume
92
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of serum prostate specific me
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients
✍ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

Predictors of prostate-specific antigen
Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy
✍ Stephen J. Freedland; William J. Aronson; Joseph C. Presti Jr.,; Christopher L. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Seminal vesicle (SV) invasion at the time of radical prostatectomy (RP) generally is considered to be indicative of poor outcome. The authors examined whether there was a subset of men with SV invasion who had long‐term prostate‐specific antigen (PSA) progression–free sur

Cancer-specific survival and predictors
Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy
✍ Fernando P. Secin; Fernando J. Bianco Jr.; Andrew J. Vickers; Victor Reuter; Tho πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 188 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme